The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?
Open accessAbstract
Traumatic brain injury (TBI) is a growing health concern effecting civilians and military personnel. Research has yielded a better understanding of the pathophysiology of TBI, but effective treatments have not been forthcoming. Near-infrared light (NIR) has shown promise in animal models of both TBI and stroke. Yet, it remains unclear if sufficient photonic energy can be delivered to the human brain to yield a beneficial effect. This paper reviews the pathophysiology of TBI and elaborates the physiological effects of NIR in the context of this pathophysiology. Pertinent aspects of the physical properties of NIR, particularly in regards to its interactions with tissue, provide the background for understanding this critical issue of light penetration through tissue. Our recent tissue studies demonstrate no penetration of low level NIR energy through 2 mm of skin or 3 cm of skull and brain. However, at 10-15 W, 0.45%-2.90% of 810 nm light penetrated 3 cm of tissue. A 15 W 810 nm device (continuous or non-pulsed) NIR delivered 2.9% of the surface power density. Pulsing at 10 Hz reduced the dose of light delivered to the surface by 50%, but 2.4% of the surface energy reached the depth of 3 cm. Approximately 1.22% of the energy of 980 nm light at 10-15 W penetrated to 3 cm. These data are reviewed in the context of the literature on low-power NIR penetration, wherein less than half of 1% of the surface energy could reach a depth of 1 cm. NIR in the power range of 10-15 W at 810 and 980 nm can provide fluence within the range shown to be biologically beneficial at 3 cm depth. A companion paper reviews the clinical data on the treatment of patients with chronic TBI in the context of the current literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Anderson, R. R., & Parrish, J. A. (1981) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12479191 · Cited by 2,456
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295
The impact of traumatic brain injuries: A global perspective
Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., & Kobusingye, O. C. (2007) · Neurorehabilitation · doi:10.3233/nre-2007-22502 · Cited by 1,816 · cited 1×
“The World Health Organization has projected that TBI soon will be the third most frequent source of disability.(1) Stroke is the second leading cause of death worldwide.”
Bashkatov, A. N., Genina, E. A., Kochubey, V. I., & Tuchin, V. V. (2005) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/38/15/004 · Cited by 1,720
The Nuts and Bolts of Low-level Laser (Light) Therapy
Chung, H., Dai, T., Sharma, S. K., Huang, Y.-Y., Carroll, J. D., & Hamblin, M. R. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0454-7 · Cited by 1,624
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
Biphasic Dose Response in Low Level Light Therapy
Huang, Y.-Y., Chen, A. C.-H., Carroll, J. D., & Hamblin, M. R. (2009) · Dose-Response · doi:10.2203/dose-response.09-027.hamblin · Cited by 1,162
Inflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
The biomedical effects of laser application
Mester, E., Mester, A. F., & Mester, A. (1985) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1900050105 · Cited by 805
Cited by
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Liu, Y., Bhattarai, P., Dai, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00618k · Cited by 2,904
Near-infrared deep brain stimulation via upconversion nanoparticle–mediated optogenetics
Chen, S., Weitemier, A. Z., Zeng, X., He, L., Wang, X., Tao, Y., Huang, A. J. Y., Hashimotodani, Y., Kano, M., Iwasaki, H., et al. (2018) · Science · doi:10.1126/science.aaq1144 · Cited by 1,126
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
Zou, L., Wang, H., He, B., Zeng, L., Tan, T., Cao, H., He, X., Zhang, Z., Guo, S., & Li, Y. (2016) · Theranostics · doi:10.7150/thno.14988 · Cited by 915
Glucose Sensing for Diabetes Monitoring: Recent Developments
Bruen, D., Delaney, C., Florea, L., & Diamond, D. (2017) · Sensors · doi:10.3390/s17081866 · Cited by 777
Plasmonic Photothermal Nanoparticles for Biomedical Applications
Kim, M., Lee, J., & Nam, J. (2019) · Advanced Science · doi:10.1002/advs.201900471 · Cited by 751
Shining light on the head: Photobiomodulation for brain disorders
Hamblin, M. R. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.002 · Cited by 627
Brain Photobiomodulation Therapy: a Narrative Review
Salehpour, F., Mahmoudi, J., Kamari, F., Sadigh-Eteghad, S., Rasta, S. H., & Hamblin, M. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0852-4 · Cited by 517
Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment
Chen, Y.-W., Su, Y.-L., Hu, S.-H., & Chen, S.-Y. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.022 · Cited by 467
Review of light parameters and photobiomodulation efficacy: dive into complexity
Zein, R., Selting, W., & Hamblin, M. R. (2018) · Journal of Biomedical Optics · doi:10.1117/1.jbo.23.12.120901 · Cited by 461
Recent Progresses in Phototherapy‐Synergized Cancer Immunotherapy
Ng, C. W., Li, J., & Pu, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804688 · Cited by 349
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
Refaat, A., Yap, M. L., Pietersz, G., Walsh, A. P. G., Zeller, J., del Rosal, B., Wang, X., & Peter, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01648-7 · Cited by 266
Gold nanoparticles enlighten the future of cancer theranostics
Guo, J., Rahme, K., He, Y., Li, L.-L., Holmes, J., & O'Driscoll, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140772 · Cited by 260
Photobiomodulation for traumatic brain injury and stroke
Hamblin, M. R. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24190 · Cited by 256
Taking phototherapeutics from concept to clinical launch
Vickerman, B. M., Zywot, E. M., Tarrant, T. K., & Lawrence, D. S. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00326-w · Cited by 201
Metadata
- Authors
- Henderson, T. A., & Morries, L.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2015-08
- Volume
- 11
- Pages
- 2191
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W1872608557
- Cited by
- 430
- References
- 98
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.